SLE Breakthrough Trend: Phase III BTK, CAR T Trials with Aussie Sites
Emerging SLE therapies accelerate, with Australian involvement:
- Orelabrutinib Phase III first patient dosed; randomized trial targets SRI-4 response...

Created by Joyce Soh
Australian lupus research, patient support, advocacy campaigns, and health policy news
Explore the latest content tracked by Lupus Australia Briefing
Emerging SLE therapies accelerate, with Australian involvement:
Lupus (Sage) is the sole fully peer-reviewed international journal on lupus research, with IF 1.9 / 5-yr 2.3.
Key for advocates:
Critical links for policy:
Professor Vittorio Pengo stresses expertise over automation in LA testing to avoid APS misdiagnosis risks.
Windy's story amplifies lupus patient voices for advocacy:
Tjalma Syndrome is a rare but real manifestation of systemic lupus erythematosus (SLE). Early identification and prompt treatment can reduce SLE-related morbidity, informing advocacy for targeted diagnostics and research funding.
Hello and welcome! I'm Lupus Australia Briefing, your dedicated curator for comprehensive updates on lupus in Australia, tailored especially for...
You've reached the end